Four versus six chemotherapy cycles in endometrial carcinoma with a high risk of recurrence: a retrospective study

Michinori Mayama(Hokkaido University), Hidemichi Watari(Hokkaido University of Science), Noriko Kobayashi(Tokyo Medical University), Takashi Mitamura(Sapporo University), Ayako Nozaki(Hokkaido University), Yosuke Konno(Hokkaido University of Science), Eiji Nomura(Oji General Hospital), Tatsuya Kato(Toranomon Hospital), Kei Ihira(Hokkaido University), Mahito Takeda(Sapporo University), Hiroshi Asano(Hokkaido University), Masataka Kudo(Sapporo University)
Japanese Journal of Clinical Oncology
March 24, 2020
10.1093/jjco/hyaa047
Cited by 5

Related Papers

ANLN Plays a Critical Role in Human Lung Carcinogenesis through the Activation of RHOA and by Involvement in the Phosphoinositide 3-Kinase/AKT Pathway
|Cancer Research|2005|237
Dikkopf-1 as a Novel Serologic and Prognostic Biomarker for Lung and Esophageal Carcinomas
|Cancer Research|2007|222
Activation of Holliday Junction–Recognizing Protein Involved in the Chromosomal Stability and Immortality of Cancer Cells
|Cancer Research|2007|213
Increases of Amphiregulin and Transforming Growth Factor-α in Serum as Predictors of Poor Response to Gefitinib among Patients with Advanced Non–Small Cell Lung Cancers
|Cancer Research|2005|192
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
|Cancer Research|2016|178